4//SEC Filing
Schoenberg Mark 4
Accession 0001437749-25-035821
CIK 0001668243other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 1:42 PM ET
Size
4.9 KB
Accession
0001437749-25-035821
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-11-19$25.00/sh−10,000$250,000→ 139,025 total
Footnotes (2)
- [F1]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 and $25.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001763581
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 1:42 PM ET
- Size
- 4.9 KB